Targeting CD38 in Neoplasms and Non-Cancer Diseases

SIMPLE SUMMARY: CD38 remains an interesting target for anticancer therapy. Its relatively high abundance in neoplasms and crucial impact on NAD+/cADPR metabolism and the activity of T cells allows for changing the immune response in autoimmune diseases, neoplasms, and finally the induction of cell d...

Descripción completa

Detalles Bibliográficos
Autores principales: Szlasa, Wojciech, Czarny, Jakub, Sauer, Natalia, Rakoczy, Katarzyna, Szymańska, Natalia, Stecko, Jakub, Kołodziej, Maksymilian, Kaźmierczak, Maciej, Barg, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454480/
https://www.ncbi.nlm.nih.gov/pubmed/36077708
http://dx.doi.org/10.3390/cancers14174169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454480/
https://www.ncbi.nlm.nih.gov/pubmed/36077708
http://dx.doi.org/10.3390/cancers14174169

Ejemplares similares